Market Overview

QIAGEN: Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase


QIAGEN N.V. announces that it will initiate the repurchase of a second
tranche of shares under the share repurchase program which was announced
by an ad hoc announcement dated January 31, 2018.

In the time period between September 5, 2018 until November 14, 2018, at
the latest, a second tranche of up to 1.65 million common shares of the
Company having a total purchase price of up to USD 50 million (or the
equivalent Euro amount thereof, in each case without ancillary
purchasing costs) shall be repurchased exclusively on the electronic
trading platform of the Frankfurt Stock Exchange (XETRA). The maximum
purchase price per share (excluding ancillary purchase costs) will not
exceed the average closing price for the last five trading days prior to
the day of purchase on the electronic trading platform of the Frankfurt
Stock Exchange by more than 10%.

The purpose of the share repurchase is to hold the shares in treasury in
order to satisfy obligations from employee share-based remuneration
plans. The Managing Board of QIAGEN N.V., upon authorization of the
Supervisory Board, is thus exercising the authorization by the Annual
General Meeting on June 21, 2017 to acquire own shares.

The repurchase program will be carried out on behalf and account of
QIAGEN N.V. through a financial institution commissioned by the Company.
The financial institution will decide on the timing of the share
purchase independently, without being influenced by the Company.

Please find the full announcement here


View Comments and Join the Discussion!